Jump to content
IndiaDivine.org

Vaccination Errors-Covered up

Rate this topic


Guest guest

Recommended Posts

http://www.timesonline.co.uk/article/0,,2099-931673_1,00.html

 

The Sunday Times Magazine

 

MMR RIP?

REPORT BY ROBERT SANDALL

 

A conspiracy of silence or paranoid scaremongering? Is the MMR vaccine a

cause of autism — or is it a vital health programme undermined by this

medical

maverick?

 

In March, seven mentally disturbed British children and an escort of

parents,

carers, two doctors and three lawyers flew to Detroit, Michigan, for a

medical test that had been denied them in the UK. The procedure, a lumbar

puncture

to extract specimens of cerebral spinal fluid (CSF), is uncomfortable and

requires anaesthetic — but it is routinely carried out in advanced western

countries in the treatment of many chronic ailments, such as leukaemia. In

the cases

of these children, all of whom were prone to seizures as well as a range of

self-harming antics, an analysis of the liquid that bathes the brain had

been

separately recommended by two neurologists.

 

Over the course of a year, the 246 private and NHS hospitals in Britain

equipped to carry out CSF taps had declined to touch them, usually on the

grounds

that the test amounted to human experimentation, not treatment. In November

2002 one hospital briefly assented before putting the matter before its

ethics

committee, which decided four months later not to proceed for the same

reason:

the children were being used as guinea pigs.

 

It was an arguable point. Before an illness can be treated, it must be fully

understood, and the root of these children's problems hadn't been

ascertained.

By the time a hospital outside Detroit agreed to accept them in March, their

parents and advisers were worrying that the tests would never take place.

They

were nearly proved right.

 

On the night before the children arrived at the hospital, lawyers acting for

GlaxoSmithKline (GSK), Merck and Aventis Pasteur MSD, manufacturers of the

MMR

triple vaccines that have been used in the UK since 1988, approached a High

Court judge in London for an injunction to prevent the CSF taps going ahead.

Two of these combination jabs had been called into question before:

Pluserix, by

Smith Kline (pre-Glaxo), and Aventis Pasteur's Immravax were withdrawn in

1992 after the " urabe " strain of mumps virus used in them was deemed

responsible

for a meningitis outbreak by the health authorities in Canada. That strain

was

replaced and M-M-R II, patented by Merck but licensed to GSK, became the

triple jab most often offered in the UK. Now the possible misbehaviour of

the

measles component was at issue. The drug companies wanted a delay because

their

medical representative needed to be present at the procedure, but couldn't

get

to Port Huron, Michigan, in time. The injunction, howeve

r, was denied.

 

The children were the claimants in a " class action " — legal-speak for a case

launched jointly by victims with the same grievance. If successful, it would

validate the claims of 1,300 other British families and trigger

international

damages awards that could top $1 trillion. The proposed test, to look for

traces of measles-vaccine virus in the children's CSF, could provide

evidence that

it can pass from the gut's lining into the brain, where measles is known to

affect cerebral processes.

 

This is one of the most contentious issues in the row about what, if

anything, brings on a disease described, but not universally accepted, as

" autistic

enterocolitis " . In the UK, the condition was first identified by Dr Andrew

Wakefield, but scientists in Japan, Norway, Ireland and the US (including

Buie,

Winter and Kushak, based at Harvard) have also published research supporting

a

link between intestinal disease and autism.

 

The theory that a malfunctioning or " leaky " gut sends partially digested

food

— in the form of opioid compounds known as peptides — up to the brain is one

of the less controversial aspects of the hypothesis under investigation.

Whether measles vaccine is what gives rise to the gut disease in the first

place

is the trillion-dollar question. So far, the sum of Wakefield et al's

discoveries has not met the exacting medical standards that establish

causation. All it

points to is an " association " . But the importance of the spinal-fluid link

was well understood by the defendants in the class action. Merck's QC had

recently referred to it in court as " a significant result when trying an

issue as to

whether or not MMR vaccine causes autism " .

 

Time was running out for the claimants. Their action was being financed by

the Legal Services Commission (LSC), a successor to the Legal Aid Board,

which

had set a July deadline for the submission of expert medical evidence, after

which funding would be reviewed. Having lost a year trying to get the CSF

samples in the UK, they now had to fly seven severely autistic, occasionally

violent

children — most of whom had never been in a plane before — halfway round the

world.

 

Another bid by the defendants to secure an injunction, this time in the US,

also failed. Then the hospital called the British party in Detroit to cancel

their appointment.

 

Although lumbar taps on autistic children are common in the US, this batch,

Lansing hospital now felt, constituted unwarranted human experimentation.

 

But the children's camp had an undisclosed back-up plan. They had made an

arrangement with another hospital in Port Huron, two hours along the shore

of

Lake Michigan, and this time, despite further delaying tactics from the

lawyers

in London, the CSF taps went ahead. One of the seven children reacted badly

to

the anaesthetic and couldn't be tested; the other six were fine.

 

Now the party and the fluid samples had to be flown home for analysis. There

was bedlam on the bus as the anaesthetic wore off: one child tried to exit

the

moving vehicle by the back door, while another was restrained by his mother

in the toilet. At the airport, the container of dry ice carrying the CSF was

deemed too large to be carried on as hand luggage, and another

business-class

seat had to be specially purchased for it.

 

After the KLM flight had boarded, five US customs officers arrived to take

the lawyers and doctors off the plane — the only passengers they

apprehended —

for separate, 30-minute taped interviews. They weren't asked any questions

pertaining to passenger safety and their large container: the issue was why

the

children hadn't been tested back in the UK. In transit at Schiphol airport

in

Amsterdam, they were again singled out for more questioning.

 

By now, several tired minds were stoking their paranoia that these

interventions might, just might, have been orchestrated to delay delivery of

the

samples, allowing them to spoil. So when the virologist in the party, Colin

Fink, got

them back to his private lab, Micropathology, in Coventry, he took the

unusual precaution of placing an armed guard outside overnight.

 

The next day the CSF samples were couriered to their final destination:

Professor John O'Leary's laboratory at Trinity College in Dublin, a facility

whose

viral-testing kit had previously identified the DNA of measles in the guts

of

autistic children. Rather disconcertingly, the package appeared to have been

opened en route, but with the war in Iraq only two days old, customs

everywhere

were on high alert.

 

The analysis proceeded: three of the six samples tested positive for the

vaccine strain of measles virus, but only in minuscule genetic fragments —

and not

enough to count as a valid research sample. According to medical-research

protocol, that result had now to be compared to the CSFs of a " control "

group of

non-autistic patients. Acquiring these took several months, during which the

claimants missed the LSC's July deadline and had their funding temporarily

suspended awaiting an appeal on September 30.

 

When the doctors finally assembled their evidence, the children's lawyers

felt confident. Only 1 in 20 of the control group — all leukaemia sufferers,

specifically chosen for their high susceptibility to random viral

infections — was

found to be carrying measles virus in their CSF.

 

The defendants' analysis of the same samples, carried out by Dr Peter

Simmonds at Edinburgh University, had found no trace of measles in the

children's

CSF. But Simmonds had chosen to use a different viral tracker, Nested,

rather

than the claimants' TaqMan process. Given the accepted centrality of

findings in

this area, they felt that their case against MMR looked strong enough to

take

to court in April 2004. But the four adjudicators on the LSC's

funding-review

committee disagreed with them. Justifying the £15m already spent as having

served the " wider public interest " , the committee stated that the £10m

needed to

see the action through " would not prove a link between MMR vaccine and

Autistic Spectrum Disorder " .

 

The claimants' lawyers suspected that the committee had made up their minds

before considering the CSF test results, as these offered fresh evidence of

just such a link. At the hearing, they were told to await a decision at the

end

of the day, and written reasons for it two days later. But if the answer was

yes, they wondered, why would the reasons not be immediately forthcoming?

 

They were not reassured to discover, when they looked more closely, that the

LSC's e-mailed press release dropping the case had been originated the day

before the hearing.In a footnote to editors, the LSC admitted that its

decision

reflected a change of policy rather than an assessment of evidence. " In

retrospect it was not appropriate for the LSC to fund research. The courts

are not

the place to prove new medical truths. " That judgment is itself up for

judicial

review in the new year — though the LSC is not bound to accept its

recommendations.

 

Paranoia is currently the default mood on all sides of the MMR debate. The

British government is so scared of it that health ministers will not be

interviewed on it. The drug companies are on the defensive against damages

claims

that, if proven, could seriously undermine their credibility and their

business.

And the anti-MMR lobby is convinced a coalition of government agencies, the

medical Establishment and big pharma are against them, X-Files style.

 

In a leafy southwest-London suburb, the man whose 1998 paper in The Lancet

kicked off the fracas, Dr Andrew Wakefield, would prefer not to talk on the

phone. He believes his line was tapped about three years ago, and now

conducts

regular " sweeps " to check it for bugs.

 

Visiting the house whose garage has served as his office since he resigned

his post at London's Royal Free hospital in 2001, it strikes you that

Wakefield

can't be doing this for the money. From the outside, his house looks as if

it

might be the only squat in an otherwise tidy, middle-class road, its

overgrown

front garden dominated by a tree stump curiously carved into a V-sign (a

message to the former chief medical officer, Sir Kenneth Calman, he later

tells

me). Unlike many of the activists in the anti-MMR camp, Wakefield is a man

unscarred by family tragedy. His four children, the eldest of whom is 13,

are as

fit as fleas, tearing around the house and back garden. All have had

vaccinations, he says, though not the MMR jab. As he first said in public in

1998, he's a

one-at-a-time man where vaccination is concerned.

 

In appearance he's like a genial fly half, solidly built, with hooded,

watchful eyes, a boyish grin and an easy manner. What bothers him most, he

says, is

the way his research has been rubbished by colleagues who deny gut treatment

to children who, he believes, badly need it. On his laptop is a photograph

of

Laurence, an autistic boy with a severely distended belly, whose mother has

been accused of starving him and was refused access to a paediatric

gastroenterologist. Next to Laurence in the picture stands his healthy,

unstarved sister.

This is a classic case of autistic enterocolitis, says Wakefield. " He's

clearly

sick. That boy and his mother are being maltreated by the medical

Establishment. " Such vehement declarations don't endear him to many of his

former

colleagues.

 

Wakefield feels pretty maltreated himself. Since qualifying in 1985, he has

published 128 papers in " peer-reviewed " journals, articles that are read and

assessed for their scientific credibility by an independent panel of up to

five

experts before being printed. His CV is a wodge of impressive titles and

tricky acronyms: The Lancet, JAMA (The Journal of the American Medical

Association). He has published 49 papers on aspects of autistic

enterocolitis, the most

recent in November's Journal of Clinical Immunology.

 

Wakefield's big beef is that his clinical findings haven't been properly

challenged on their own terms. He conducts or collates the results of

colonoscopies and biopsies of particular children. He calls this " scoping

the kids " . His

opponents take a different tack: some have failed to replicate his findings

using different clinical procedures and technologies. Others say his samples

are

too minute, anatomically and numerically, and examine the statistical

incidence of autism versus uptake of MMR, and any adverse aftereffects.

Study after

study has found no correlation. Research published this year in America

found a

" statistically significant " risk of autism in cases reported 5 to 10 days

after MMR, but in general the statistics suggest that Wakefield is making a

mountain out of a molehill.

 

But the way this data is compiled and analysed is troubling. In Britain, the

reporting of bad vaccine reactions is down to parents and harassed GPs, who

have to fill out and forward yet another form to a national database, the

so-called " yellow-card " system. Big studies abroad, in Finland in 1998 and

Denmark

last year, found nothing to worry about. But a similarly reassuring analysis

in

the US, published in the November issue of Pediatrics, has started a

firestorm in Washington. A transcript of a conversation at the federal

Center for

Disease Control and Prevention (CDC), obtained under the Freedom of

Information

Act, revealed officials admitting that data on MMR could be manipulated to

prove, or disprove, anything. The US representative Dave Weldon, a qualified

doctor

himself, wrote an open letter to the head of the CDC, noting its " selective

use of data " and pointing out that the lead author of the study left the CDC

two years ago to work for GlaxoSmithKline.

 

Wakefield, too, has taken a bit of stick from public officials recently.

" Junk science " — a term used earlier this year by a High Court judge

awarding in

favour of a suit brought by two estranged husbands against their wives'

decision not to give the triple jab to their children — particularly

rankles. Why

wasn't he called as the expert witness for the defence, rather than Jayne

Donegan, a homeopath and GP from south London, he wonders. (Donegan was

reprimanded

by the judge for not answering the court's questions.) " It was a disgrace.

We've published a lot on this in eminent journals. The first we heard of

that case

was when it was thrown out of court. "

 

Life was different before he and six of his Royal Free team published their

Lancet bombshell, the unexplosively titled " Ileal-Lymphoid-Nodular

Hyperplasia,

Non-Specific Colitis and Developmental Disorder in Children. " Up until 1998,

Wakefield had been a whiz-kid. His discovery that an inflammatory bowel

disease, ulcerative colitis, can be brought on by arterial problems rather

than, as

was previously assumed, by a gut full of germs, made his name. It also

established his modus operandi. As a trained surgeon, he based his research

on

observation rather than textbook precedents.

 

Wakefield's next hypothesis was more controversial: the presence of measles

virus in the wrecked intestines of sufferers of Crohn's disease — a finding

that was not replicated in worldwide studies set up by the World Health

Organization in 2000 — led him to his first brush with big pharma. His

co-funders,

Merck, pulled out just before he published in 1996. Though he had previously

received half a dozen research grants, totalling around $500,000, from Glaxo

and

Hoffman-LaRoche as well as Merck, his drug-company funding now disappeared.

So

he recruited a medical fundraiser, Robert Sawyer, to tap alternative

philanthropic bodies, and ploughed on looking for gut measles. When Rosemary

Kessick,

the mother of an autistic child, came to him convinced her son's problems

were

related to the chronic diarrhoea he developed after having the MMR jab,

Wakefield listened and looked.

 

Conventional diagnosis attributed the concurrence of autistic behaviour and

severe bowel problems to coincidence, or held that disturbed minds naturally

led to upset tummies. Wakefield wondered if the reverse might be true. Could

" leaky guts " play a role in developmental problems? And if so, could these

problems be alleviated by addressing the inflamed intestines? Other

specialists

regarded autistic children as medically untreatable, and none of Wakefield's

business: he was a gut man. But the interventions he proposed seemed to

work. Among

the 200 or so children he oversaw, on average four times a year each at the

Royal Free, their behavioural problems appeared to subside, though not

disappear, as their guts healed. " These kids were often in extreme pain, and

that was

why they were screaming or banging their heads on the wall. "

 

In the 12 cases that he and his team examined in detail, the children's

bowel

problems coincided with evidence suggesting that measles was lurking in the

intestinal wall. Given the known propensity of measles to linger in the gut

and, in extreme cases, to attack the brain, might this implicate MMR in

their

children's autism?

 

It was, to put it mildly, an awkward question. Wakefield had already raised

eyebrows by treating patients traditionally cared for by psychiatrists,

virologists and community paediatricians. One of the latter had complained

in a

letter to a colleague in 1987 about " a zealot surgeon who thinks that MMR is

the

cause of all the problems in the western world " . Now others accused him of

over-egging the Lancet article. " Anecdotal reporting of a biased sample, " one

complained. " This has no place in a peer-reviewed journal. "

 

And soon the fur started to fly. Wakefield had cooked the evidence by

concentrating on just 12 cases. His research facilities were contaminated.

He

couldn't replicate his own results. The last of these charges was true

enough. For

the first few years, his research results were inconsistent and

contradictory.

He blames this on the measuring technology. He says that changed in 1999

with

Professor John O'Leary and his TaqMan viral detector, a machine sensitive

enough to pick up minute traces of measles vaccine DNA in 75 autistic

children with

disorderly bowels. O'Leary has refused to finger MMR but he has demanded

" extensive and immediate investigation " into the link. The presence of

vaccine-strain measles, as opposed to the " wild " variety, O'Leary referred

to as " a

smoking gun " .

 

The Department of Health (DoH) was not impressed. Despite Wakefield's

submissions to the then chief medical officer, Kenneth Calman, six months

prior to

publication of the 1998 Lancet article, public-health officials were

understandably resistant to a hypothesis that queried their vaccination

programme on the

basis of one small group of children in north London. But not as resistant

as

the drug companies who, as they generally do in teaching hospitals,

sponsored

a large chunk of the Royal Free's research. Everybody, Wakefield and co

included, agreed that more studies were needed before MMR could be shown as

a cause

of autism. Not everybody, though, was urging that these should take place.

 

Over the next three years, Wakefield saw his research funding dry up. He

blames his bosses at the Royal Free for discouraging potential donors. They

blamed

him for being " evangelical " and needlessly scaring parents. Two key members

of his team, Paul Ashwood and Scott Montgomery, found themselves with little

to

do, and took up new posts, in California and Stockholm, from where they have

continued the collaboration.

 

Not all of Wakefield's team were as convinced as him that MMR was the

culprit. One of the co-authors of the 1998 Lancet paper, Simon Murch, senior

lecturer

in paediatric gastroenterology at the Royal Free, recently declared his

belief that MMR is safe in a letter to The Lancet headlined " Separating

Speculation

from Inflammation in Autism " . Murch made his move on the eve of publication

of a study, by himself, Wakefield and others, which compares the aggressive

behaviour of gut measles to HIV, adding more fuel to the

conspiracy-theorists'

view that scientists connected with Wakefield are being pressurised to

recant.

When asked, Murch declined to comment.

 

Unlike Murch, who stayed put, Wakefield left the Royal Free, " because it

became increasingly obvious that if we were going to get an answer to this,

we had

to work outside of an environment where I was getting more involved in

personal wrangles and the attrition of grants " , he says. Robert Sawyer

jumped ship

at the same time to set up a charity, Visceral, that investigates

gut-mediated

illnesses and supports projects that test Wakefield's theories.

 

Visceral's head, and only, office is a converted broom cupboard in the

centre

of Bath from which Sawyer describes himself as running " a virtual medical

school " , one that has paid out £1.8m grants to 31 lab scientists around the

world. His funding sources are mainly small charitable foundations in the UK

and

US, set up to support independent research (there are around 50,000 in the

UK

alone). Visceral, he says forcefully, will not take money from cranks who

believe that all vaccinations are the devil's work. They are currently

funding work

on genetic mechanisms that may be perverted by a malign viral presence in

the

gut, and which lead the body's immune system to turn on itself — " aberrant

signalling " . The search for the virus that sets it off is a clinical

whodunnit in

which he and Wakefield still have measles vaccine down as their chief

suspect.

 

Almost everybody who speaks out on MMR has a defined stake in it. My reason

for getting into all of this is simple: Anita and I have a 16-month-old

daughter, and we have a tricky decision to make.

 

How her developing immune system will benefit from getting three vaccines in

one go, rather than having them singly and spread out over a few months, has

not been adequately explained. On the other hand, Wakefield's belief in

" viral

interference " — a tendency for invading viruses to do more damage when

they're

combined — sounds plausible. He quotes three papers published in America and

Japan between 1969 and 1974, identifying the dual presence of the mumps and

measles viruses as a factor that can make the measles more virulent and

dangerous.

 

The DoH derides this as a " myth " but doesn't explain why on its web page:

MMR

The Facts. And there is another fact to be considered: the British

government's recent acknowledgment that " Gulf-war syndrome " exists. Most of

the military

personnel afflicted believe it was brought on by multiple vaccinations prior

to the 1991 conflict. The government hasn't publicly confirmed this but,

tellingly, when British troops were sent to Iraq this year, their jabs were

not all

given at once.

 

Multiple vaccinations are not my thing. I am of an older generation that was

expected, even encouraged, to catch measles and mumps in early life and get

over them. The first I knew that I had survived a killer illness was when

Edwina

Currie, the health minister who introduced MMR in 1988, revealed that we

were

" losing a child a month in this country " to measles.

 

Which was not strictly true. In the year before MMR came in, the Public

Health Laboratory Service counted six deaths from a reported 42,000 measles

cases.

That rate has subsequently declined from 1 in 7,000 to 1 in 10,000. SSPE

(subacute sclerosing panencephalitis), in which measles destroys the brain

in a

manner similar to variant CJD, hits about 1 in 8,000 children who catch the

disease before the age of two. Measles epidemics are undoubtedly nasty: 130

children died in the last big outbreak in the United States in 1989.

 

When the single measles jab was introduced here in 1968, it was urged not so

much as a life-saver, but as a means of relieving pressure on GPs during

epidemics. Its early popularity related to other side effects that afflict

measles

sufferers, such as impaired eyesight. Mumps vaccine, on the other hand, was

a

harder sell. Mumps can cause sterility in adults but only rarely damages

children, and the single mumps jabs did not catch on. Bundling these two

vaccines

with the rubella jab, previously given only to girls at age 12, and offering

the package to all children at 15 months, seemed from the outset to have

more to

do with administrative convenience than with public health.

 

In its 1988 HMSO Handbook of Vaccination for Practitioners, the DoH claimed

a

95% protection rate for the rubella-and-measles single jabs. In its 1996

edition, post-MMR, the measure of effective measles immunity had dropped to

90% —

beneath the threshold guaranteeing " herd immunity " . But by now the DoH's

data-collection system no longer recognised single jabs in the compiling of

individual health records.

 

Today we are informed that MMR is more effective than single vaccines, as

well as unimpeachably safe. But government ministers are reluctant to

address the

issue in detail, preferring to issue bland reassurances such as the one the

health secretary, John Reid, made on GMTV in November: " It is unequivocal

that

there is no evidence at all that MMR is linked to autism. "

 

Off the record, however, DoH media briefers acknowledge that MMR has become

" too political " . After receiving wobbly guidance on poisoned eggs, mad-cow

disease and the anti-arthritic drug Opren, the public no longer believes

elected

politicians on health issues, so comments on MMR are kept to a minimum.

David

Salisbury has presided over all vaccination programmes for the past 15

years,

and currently advises the junior minister for public health, Melanie

Johnson.

 

Neither of them would speak to me about a successor to MMR that was first

revealed in the press in 1998, shortly before the Wakefield paper. This was

MMRV —

V as in varicella, or chickenpox. The DoH now denies any interest in this,

possibly because research on MMRV has shown it doesn't work. A study partly

funded by GlaxoSmithKline, published last year by the University of

Melbourne,

found that quadruply vaccinated children were more prone to suffer fevers

immediately afterwards than those given MMR and varicella vaccines

separately.

Worse, they did not develop a significant immunity to chickenpox after 60

days. But

the drug companies haven't given up: recent press reports tell of more tests

on MMRV proceeding in Sheffield. The DoH says it is " not aware of such a

product being available for use in the UK " .

 

The row about MMR derives in part from a chronic uncertainty as to what

autism describes. A year after it was identified in 1943, by Leo Kanner in a

study

of 11 profoundly uncommunicative, unruly children, a variant — Asperger's

syndrome — proposed a less serious version, in which poor social skills are

offset

by an obsessive attention to detail that can lead to high academic

performance. For years, autism was thought to be caused by unloving parents,

and

" refrigerator mothers " in particular. In the 1960s it was redefined as an

inherited

brain disorder, and then came a distinction between classic congenital

autism

and a regressive variety acquired after the age of two.

 

Autism is now referred to as a spectrum disorder, a catch-all syndrome whose

symptoms range from semi-suicidal lunges out of windows to a relatively

harmless obsession with order and routine. Wakefield's theories about leaky

guts

blur definitions further by challenging the traditional view that autism is

a

purely psychiatric problem, and arguing that it can be treated by medical

means

as well as by behavioural therapies.

 

One thing that is apparent is that there is a lot more of it about nowadays.

We all know, or know of, somebody with an afflicted child. Authors, notably

Nick Hornby, whose ex-wife Virginia used to be a trustee of Visceral, have

written about their experiences as parents. Official statistics from the

Medical

Research Council (MRC) in 2001 revealed the rate had shot up from 1 in 5,000

per

head of population in 1970 to 1 in 165. In 1988, when MMR was introduced, it

was 1 in 2,200.

 

That might be coincidence, and it might be that as the spectrum of the

disorder has broadened, we've got better at spotting it. Wakefield's former

colleague at the Royal Free, Professor Brent Taylor, last year published a

statistical

analysis of children in north London showing that an autism epidemic was

well

under way before MMR. Then it was pointed out by Wakefield and Montgomery

that many children in the survey who appeared, from their date of birth, not

to

have had the triple jab but who still developed autism, might have been

included in an extensive " catch-up " MMR campaign targeted at older children

in the

early 1990s. Taylor later acknowledged this in a letter to The Lancet, but

stands by his broad findings.

 

In response to my request for clarification, he replied that " the scientific

argument on MMR and autism is over: MMR vaccine is not involved " . He urged

The

Sunday Times to " do something positive " for MMR and for children with

autism,

instead of " another half-baked panagyric [sic] for junk science " . I pressed

him to explain what he meant by " junk science " . He didn't mail me back.

 

Such reticence from the pro-MMR party does not inspire confidence. Nor do

their efforts to identify alternative causes for the steep increase in

diagnosed

autism. The Medical Research Council was given £2.75m by the DoH last year

to

fund new research. So far, none of that money has been allocated, though 12

projects are, it says, " under consideration " . No details could be supplied.

 

Meanwhile a three-year study that the MRC commissioned in 2000 from the

London School of Hygiene & Tropical Medicine has not yet reported. Two

papers are

being readied for publication, one assessing the rise in autism since 1988

and

another looking at possible links with MMR. The scientist in charge,

Professor

Andrew Hall, has inspected the GP records of 1,000 children diagnosed as

autistic and sent questionnaires to 400 parents. Since none of Hall's team

has

been near an autistic child, whatever he reports is unlikely to silence

Wakefield

and the " scopers " . It's stats against case studies, the old

apples-versus-oranges argument. Again.

 

On the day the Legal Services Commission announced it was pulling out of the

MMR class action, the DoH endorsed that, stating that " this draws a line "

under the controversy. Some hope.

 

Tomorrow, Five is scheduled to screen a TV drama, Hear the Silence, with

Hugh

Bonneville as Andrew Wakefield and Juliet Stevenson as the mother of an

autistic child battling to get heard by an unsympathetic gang of haughty

specialists. It is a partisan account of the MMR story, so partisan that

Five has

organised a televised discussion afterwards to let the DoH answer back. At

the time

of writing, it had not agreed to take part.

 

The most misleading impression given by the drama is its portrayal of

Wakefield as a gallant loner. In October, I flew to Portland, Oregon, to

attend a

conference hosted by the American pressure group Defeat Autism Now! (Dan!),

where

Wakefield was one of 23 research scientists — all confirmed as anti-MMR —

making presentations to an audience of medics and parents. The last speaker

was

Rick Rollens, formerly secretary to the California state senate, and the

father of an autistic son.

 

He presented a torrent of statistics detailing an 800% increase in diagnosed

cases of autism since California introduced MMR jabs in 1979 and made them

compulsory, in line with a nationwide Clinton decree in 1993. The state's

Developmental Services Agency now finds that just under half its clients are

autistic, compared with the 3% it dealt with pre-MMR. The epidemic, Rollens

said, was

threatening to wreck care provision in the nearly bankrupt public

administration of California.

 

This was a depressing and biased presentation. But at least it dealt in what

looked like hard facts. Shortly after returning from Dan!, I attended a

public

seminar in London that addressed the MMR/autism issue in ostrich-like

fashion. It was hosted by the PR company Hill & Knowlton, whose clients

includes the

three drug companies that manufacture the triple vaccine, and it was

introduced by an online magazine, Spiked, one of whose columnists, the east

London GP

Michael Fitzpatrick, led the discussion. The audience was chiefly composed

of

health professionals, DoH representatives and media types. Two things stood

out.

 

One was the meeting's concern that anxieties about MMR had been hyped by our

old enemy the media. The other was its refusal to address the evidence that

aroused public distrust in the first place. For these people, immunisation

was

an incontrovertible religious doctrine. Fitzpatrick rubbished the work of

Wakefield, whose research papers currently outnumber his own by 128 to 0, as

a

superstition on a par with astrology. When somebody mentioned the divergence

of

scientific opinion, Professor Brent Taylor interrupted, again announcing

that

" the scientific debate is over " .

 

Andrew Wakefield has no plans to belt up. More studies are in the pipeline —

so, no doubt, are more allegations of cover-ups and conspiracies. If

Wakefield

is proved right, then we've been poisoning our offspring, avoidably, since

his 1998 study. If he's wrong, then let's hear some intelligible evidence

ASAP,

so we can get MMR vaccination rates up — from 67% in the London area and

under

80% across the country — to head off threatened measles epidemics. And

single

vaccinations need to be reinstated as an affordable alternative to the

worrisome triple jab. A typical price for a private measles jab is £150.

 

Having spent £3m on a TV ad campaign urging triple vaccination, with a

prowling lion protecting its young — which didn't work — the DoH's current

course

is to carry on ignoring Wakefield et al.

 

A low-profile series of educational road shows and advice sessions in the 20

areas of the country with the lowest take-up of MMR began in the summer. In

London, the country's anti-MMR capital, these have been almost invisible.

 

Such a feeble defence of the status quo, and a blanking of public anxieties

that might be misguided but are nonetheless genuine, may suit embattled drug

companies and embarrassed government policy wonks. But it isn't going to

silence

the enemies of multiple vaccination — nor will it do much good for anybody's

health.

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...